RxCell

About RxCell

RxCell is a leading biotechnology company focused on advancing therapeutic applications through induced pluripotent stem cells (iPSC). Driven by a passion for groundbreaking research, RxCell is committed to pioneering innovations in regenerative medicine.

Products & Services

Retinal Progenitor Cells:Developed from therapeutic-grade iPSC master cell banks (MCB) under current good manufacturing practice (cGMP), currently in the process of manufacturing for an IND application with the FDA.

Specialties

Induced Pluripotent Stem Cells (iPSC) Regenerative Medicine Retinal Cell Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment T: - FT: Investment	A: 4600000 MR: - FA: $4,600,000 FAN: 4600000	D: 2023-12-05 FD: 2023-12-05	2 investors

Investment Latest

2023-12-05

$4.6M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

RxCell Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised